Fangchao Xue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fangchao Xue has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Hao Tian
Department of Cell Biology, Third Military Medical University, Chongqing, China
2 shared publications - Haoxiang Qin
Department of Cell Biology, Third Military Medical University, Chongqing, China
2 shared publications - Shanlan Zhao
Department of Cell Biology, Third Military Medical University, Chongqing, China
2 shared publications - Wen Zeng
Department of Cell Biology, Third Military Medical University, Chongqing, China
2 shared publications Wenyan Zhao
2 shared publications- Xiaochen Li
Department of Cell Biology, Third Military Medical University, Chongqing, China
2 shared publications
Latest Publications
- Open Access
- 5 February 2024
- Published by Elsevier in Composites Part B: Engineering
- Vol. 275
Composite materials combined with stem cells promote kidney repair and regeneration
- 5 February 2024
- Published by Elsevier in Composites Part B: Engineering
- Vol. 275
Open AccessComposite materials combined with stem cells promote kidney repair and regeneration
- Open Access
- 29 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Two way workable microchanneled hydrogel suture to diagnose, treat and monitor the infarcted heart
During myocardial infarction, microcirculation disturbance in the ischemic area can cause necrosis and formation of fibrotic tissue, potentially leading to malignant arrhythmia and myocardial remodeling. Here, we report a microchanneled hydrogel suture for two-way signal communication, pumping drugs on demand, and cardiac repair. After myocardial infarction, our hydrogel suture monitors abnormal electrocardiogram through the mobile device and triggers nitric oxide on demand via the hydrogel sutures’ microchannels, thereby inhibiting inflammation, promoting microvascular remodeling, and improving the left ventricular ejection fraction in rats and minipigs by more than 60% and 50%, respectively. This work proposes a suture for bidirectional communication that acts as a cardio-patch to repair myocardial infarction, that remotely monitors the heart, and can deliver drugs on demand.
- 29 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessTwo way workable microchanneled hydrogel suture to diagnose, treat and monitor the infarcted heart
During myocardial infarction, microcirculation disturbance in the ischemic area can cause necrosis and formation of fibrotic tissue, potentially leading to malignant arrhythmia and myocardial remodeling. Here, we report a microchanneled hydrogel suture for two-way signal communication, pumping drugs on demand, and cardiac repair. After myocardial infarction, our hydrogel suture monitors abnormal electrocardiogram through the mobile device and triggers nitric oxide on demand via the hydrogel sutures’ microchannels, thereby inhibiting inflammation, promoting microvascular remodeling, and improving the left ventricular ejection fraction in rats and minipigs by more than 60% and 50%, respectively. This work proposes a suture for bidirectional communication that acts as a cardio-patch to repair myocardial infarction, that remotely monitors the heart, and can deliver drugs on demand.
- Open Access
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (29) , eadf7858
Engineered exosomes reprogram Gli1 + cells in vivo to prevent calcification of vascular grafts and autologous pathological vessels
Calcification of autologous pathological vessels and tissue engineering blood vessels (TEBVs) is a thorny problem in clinic. However, there is no effective and noninvasive treatment that is available against the calcification of TEBVs and autologous pathological vessels. Gli1 + cells are progenitors of smooth muscle cells (SMCs) and can differentiate into osteoblast-like cells, leading to vascular calcification. Our results showed that the spatiotemporal distribution of Gli1 + cells in TEBVs was positively correlated with the degree of TEBV calcification. An anticalcification approach was designed consisting of exosomes derived from mesenchymal stem cells delivering lncRNA-ANCR to construct the engineered exosome-Ancr/E7-EXO. The results showed that Ancr/E7-EXO effectively targeted Gli1 + cells, promoting rapid SMC reconstruction and markedly inhibiting Gli1 + cell differentiation into osteoblast-like cells. Moreover, Ancr/E7-EXO significantly inhibited vascular calcification caused by chronic kidney disease. Therefore, Ancr/E7-EXO reprogrammed Gli1 + cells to prevent calcification of vascular graft and autologous pathological vessel, providing unique insights for an effective anticalcification.
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (29) , eadf7858
Open AccessEngineered exosomes reprogram Gli1 + cells in vivo to prevent calcification of vascular grafts and autologous pathological vessels
Calcification of autologous pathological vessels and tissue engineering blood vessels (TEBVs) is a thorny problem in clinic. However, there is no effective and noninvasive treatment that is available against the calcification of TEBVs and autologous pathological vessels. Gli1 + cells are progenitors of smooth muscle cells (SMCs) and can differentiate into osteoblast-like cells, leading to vascular calcification. Our results showed that the spatiotemporal distribution of Gli1 + cells in TEBVs was positively correlated with the degree of TEBV calcification. An anticalcification approach was designed consisting of exosomes derived from mesenchymal stem cells delivering lncRNA-ANCR to construct the engineered exosome-Ancr/E7-EXO. The results showed that Ancr/E7-EXO effectively targeted Gli1 + cells, promoting rapid SMC reconstruction and markedly inhibiting Gli1 + cell differentiation into osteoblast-like cells. Moreover, Ancr/E7-EXO significantly inhibited vascular calcification caused by chronic kidney disease. Therefore, Ancr/E7-EXO reprogrammed Gli1 + cells to prevent calcification of vascular graft and autologous pathological vessel, providing unique insights for an effective anticalcification.